The Effects of Tolvaptan on Patients With Severe Chronic Kidney Disease Complicated by Congestive Heart Failure

Clinical and Experimental Nephrology - Japan
doi 10.1007/s10157-013-0788-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patient Selection for the Tolvaptan Therapy Among Those With Chronic Kidney Disease and Heart Failure

Therapeutic Apheresis and Dialysis
HematologyNephrology
2019English

Intermittent, Ambulatory Dobutamine Infusions in Patients With Severe Congestive Heart Failure

American Heart Journal
Cardiovascular MedicineCardiology
1986English

Efficacy and Safety of Goreisan for Chronic Heart Failure Patients With Chronic Kidney Disease

Kampo Medicine
2019English

Effects of Amrinone on Myocardial Energy Metabolism and Hemodynamics in Patients With Severe Congestive Heart Failure Due to Coronary Artery Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1980English

Short and Long-Term Effects of Treatment With Low Dose Captopril in Patients With Severe Congestive Heart Failure.

British Journal of Clinical Pharmacology
Pharmacology
1982English

Impact of Chronic Congestive Heart Failure on Pharmacokinetics and Vasomotor Effects of Infused Nitrite

British Journal of Pharmacology
Pharmacology
2013English

Neuroendocrine Response to Standing and Mild Exercise in Patients With Untreated Severe Congestive Heart Failure and Chronic Constrictive Pericarditis.

Heart
Cardiovascular MedicineCardiology
1996English

The Outcomes of Chronic Kidney Disease and Heart Failure With Reduced Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Prognostic Factors in Patients With Congestive Heart Failure

Arquivos Brasileiros de Cardiologia
Cardiovascular MedicineCardiology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy